Literature DB >> 11741749

Genetic alterations in endometrial hyperplasia and cancer.

Gerhild Fabjani1, Elisabeth Kucera, Eva Schuster, Michael Minai-Pour, Klaus Czerwenka, Gerhard Sliutz, Sepp Leodolter, Angelika Reiner, Robert Zeillinger.   

Abstract

Putative precursors of endometrial cancer such as complex endometrial hyperplasia with atypia have been described to be monoclonal and considered to be genetically related. In order to identify a genetic marker that could serve as a putative predictor of endometrial cancer we analyzed 14 endometrial hyperplasia and 29 endometrial cancer samples for instabilities and loss of heterozygosity (LOH) in microsatellite sequences. Deletions on the short arm of chromosome 8 were frequently detected in both endometrial hyperplasia and cancer samples, suggesting that these deletions are early events in the development of endometrial cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11741749     DOI: 10.1016/s0304-3835(01)00714-5

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Establishment and characterization of a new human cell line (EJ) derived from endometrial carcinoma.

Authors:  Keiichi Isaka; Hirotaka Nishi; Toshihide Nakada; Yumi Osakabe; Mitsuyasu Hokamura; Hiromi Serizawa; Yoshiro Ebihara; Masaomi Takayama
Journal:  Hum Cell       Date:  2002-12       Impact factor: 4.174

2.  Sensitive detection of KRAS mutations in archived formalin-fixed paraffin-embedded tissue using mutant-enriched PCR and reverse-hybridization.

Authors:  Christoph Ausch; Veronika Buxhofer-Ausch; Christian Oberkanins; Barbara Holzer; Michael Minai-Pour; Stephan Jahn; Nadia Dandachi; Robert Zeillinger; Gernot Kriegshäuser
Journal:  J Mol Diagn       Date:  2009-10-01       Impact factor: 5.568

3.  Digitally guided microdissection aids somatic mutation detection in difficult to dissect tumors.

Authors:  Katherine Geiersbach; Nils Adey; Noah Welker; Danielle Elsberry; Elisabeth Malmberg; Sumie Edwards; Erinn Downs-Kelly; Mohamed Salama; Mary Bronner
Journal:  Cancer Genet       Date:  2015-12-15

Review 4.  Therapeutic options for management of endometrial hyperplasia.

Authors:  Vishal Chandra; Jong Joo Kim; Doris Mangiaracina Benbrook; Anila Dwivedi; Rajani Rai
Journal:  J Gynecol Oncol       Date:  2015-12-01       Impact factor: 4.401

5.  Establishment and characterization of novel human primary endometrial cancer cell line (ZJB-ENC1) and its genomic characteristic.

Authors:  Xiaozhen Liu; Zhuozhuo Ren; Yu Xu; Wei Sun; Yongfeng Li; Xinmiao Rui; Dafei Xie; Xuli Meng; Zhiguo Zheng
Journal:  J Cancer       Date:  2019-10-20       Impact factor: 4.207

6.  Performance of Automated Dissection on Formalin-Fixed Paraffin-Embedded Tissue Sections for the 21-Gene Recurrence Score Assay.

Authors:  Peng Qi; Qian-Ming Bai; Qian-Lan Yao; Wen-Tao Yang; Xiao-Yan Zhou
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

Review 7.  Current and Future Roles of Circular RNAs in Normal and Pathological Endometrium.

Authors:  Jiajie Tu; Huan Yang; Yu Chen; Yu Chen; He Chen; Zhe Li; Lei Li; Yuanyuan Zhang; Xiaochun Chen; Zhiying Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-26       Impact factor: 5.555

8.  KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay.

Authors:  Veronika Auner; Gernot Kriegshäuser; Dan Tong; Reinhard Horvat; Alexander Reinthaller; Alexander Mustea; Robert Zeillinger
Journal:  BMC Cancer       Date:  2009-04-09       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.